280 PI3K/AKT pathway is involved in myelodysplastic syndrome progression
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2011 |
---|---|
Erschienen: |
2011 |
Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
---|---|
Enthalten in: |
Leukemia research - 35(2011), 1, SUPPL, Seite 1-2 |
Beteiligte Personen: |
Rezende, D.C. [VerfasserIn] |
---|
BKL: |
---|
Umfang: |
1 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
OLC1870041208 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | OLC1870041208 | ||
003 | DE-627 | ||
005 | 20230507083347.0 | ||
007 | tu | ||
008 | 110524s2011 xx ||||| 00| ||und c | ||
028 | 5 | 2 | |a sw110522_1 |
035 | |a (DE-627)OLC1870041208 | ||
035 | |a (DE-599)GBVOLC1870041208 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
082 | 0 | 4 | |a 610 |
084 | |a 44.00 |2 bkl | ||
100 | 1 | |a Rezende, D.C. |e verfasserin |4 aut | |
245 | 1 | 0 | |a 280 PI3K/AKT pathway is involved in myelodysplastic syndrome progression |
264 | 1 | |c 2011 | |
300 | |a 1 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
700 | 1 | |a Kimura, E.Y.S. |4 oth | |
700 | 1 | |a Pacheco, L.Z.C. |4 oth | |
700 | 1 | |a Silva, M.C.A. |4 oth | |
700 | 1 | |a Yamamoto, M. |4 oth | |
700 | 1 | |a Chauffaille, M.L. |4 oth | |
700 | 1 | |a Kerbauy, D.B. |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Leukemia research |d Amsterdam : Elsevier, 1977 |g 35(2011), 1, SUPPL, Seite 1-2 |w (DE-627)168449080 |w (DE-600)752396-8 |w (DE-576)016070305 |x 0145-2126 |7 nnns |
773 | 1 | 8 | |g volume:35 |g year:2011 |g number:1 |g supplement:SUPPL |g pages:1-2 |g extent:1 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4219 | ||
936 | b | k | |a 44.00 |q AVZ |
951 | |a AR | ||
952 | |d 35 |j 2011 |e 1 |f SUPPL |h 1-2 |g 1 |